Vancouver Television · National

Nova Scotia urged to speed up HPV testing for cervical cancer screening

Nova Scotia urged to speed up HPV testing for cervical cancer screening

Nova Scotia opposition leaders and a gynecological cancer specialist are urging the province to switch to HPV testing for cervical cancer screening sooner than planned.

The Story

Nova Scotia’s official Opposition is calling on the Tim Houston government to speed up the province’s shift from traditional Pap tests to human papillomavirus, or HPV, testing for cervical cancer screening.

Speaking at a news conference, NDP Leader Claudia Chender said the province should “finally ditch the outdated Pap test” in favour of what she called a “better, more affordable” approach.

Chender and gynecological cancer specialist Dr. Robert Grimshaw said plans to make the switch have been in progress for more than two years.

Nova Scotia Health had previously shared plans to use HPV testing as the preferred method during a legislative committee hearing in July 2024.

Grimshaw said the HPV test is highly effective because human papillomavirus is responsible for almost 100% of cervical cancers. He said it is also easier to reach people in rural areas or those who have difficulty accessing primary care because it can be administered at home and sent back to labs by mail.

He said Nova Scotia has the highest cervical cancer rate in Atlantic Canada and the second-highest rate in the country, and he pointed to 11 per 100,000 Nova Scotia women per year recorded as having cervical cancer in 2022, based on the most recent data from the Canadian Partnership Against Cancer.

A Department of Health spokesperson, Brooke Armstrong, said the province is working on the switch and is aware that other provinces are further ahead. Armstrong said the health system needs appropriate lab capacity, equipment and specialists, as well as a patient follow-up system, adding that “work is underway to help us better understand those requirements and inform how we might make the transition.”

Grimshaw also said that at the time of the July 2024 legislative committee hearing, he expected the new program would roll out in six months to a year, but that “we just haven’t been able to get any traction.”

He said machines currently used for HPV testing in Nova Scotia’s colposcopy clinics could accommodate primary HPV testing for women in the province “without any capital expenditure,” while acknowledging there would be upfront costs.

Grimshaw said estimates suggest the province would save between three dollars and $25 for every dollar spent on an HPV testing program.

Chender said she is struggling to understand why Nova Scotia has not moved faster on the switch, saying the delay suggests a “lack of political will.”

Canada has set a goal of eliminating cervical cancer before 2040, and Grimshaw pointed to prevention through vaccination and improved screening as part of that effort. He said the National Advisory Committee on Immunization recommends a single dose for school-aged children and noted that vaccination has been shown to prevent up to 90% of cancers caused by the virus. Research he cited, examining data from 2014-18 in 14 countries including Canada, found an 83% reduction in two main cancer-causing HPV types among girls who received the vaccine.

← More stories